فضلا اضغط بالاسفل
يستعمل دواء نوفوسيفين 1.2مجم فيال novoseven 1.2mg i.v. vial(n/a) blood coagulation factor blood coagulation factor
novoseven�is recombinant human coagulation factor viia (rfviia) intended for promoting hemostasis by activating the extrinsic pathway of the coagulation cascade. novoseven (coagulation factor viia recombinant) is a vitamin k-dependent glycoprotein consisting of 406 amino acid residues (mw 50 k dalton). novoseven (coagulation factor viia recombinant) is structurally similar to human plasma-derived factor viia. - -indications: -*treatment of bleeding episodes in hemophilia a or b patients with inhibitors to factor viii or factor ix and in patients with acquired hemophilia. -*prevention of bleeding in surgical interventions or invasive procedures in hemophilia a or b patients with inhibitors to factor viii or factor ix and in patients with acquired hemophilia. -*treatment of bleeding episodes in patients with congenital fvii deficiency. -*prevention of bleeding in surgical interventions or invasive procedures in patients with congenital fvii deficiency
تركيبة دواءنوفوسيفين 1.2مجم فيال novoseven 1.2mg i.v. vial(n/a)
يتركب هذا الدواء من :blood-coagulation factor vii
الشركة المنتجة لدواءنوفوسيفين 1.2مجم فيال novoseven 1.2mg i.v. vial(n/a)
هذا الدواء من انتاج شركة novo nordisk
جرعة دواءنوفوسيفين 1.2مجم فيال
Welcome to Dlildwa, specifically the page of novoseven 1.2mg i.v. vial(n/a).
تم استعراض بدائل هذا الدواء 248 مرة